A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients — Stella
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
(6 sites) United States
University of California Los Angeles Health System, Los Angeles, California University of California, San Diego, San Diego, California University of Miami Health System, Miami, Florida Boston Medical Center, Boston, Massachusetts University of Washington Health System, Seattle, Washington University of Wisconsin-Madison, Madison, Wisconsin Key details Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
University of California, Los Angeles, University of California, San Diego
Enrollment target
~400,000 participants
Primary completion
March 2028
Age range
18 Years and older
Last updated November 2025